Skip to main content
Sinopharm Group Co. Ltd. logo

Sinopharm Group Co. Ltd. — Investor Relations & Filings

Ticker · 1099 ISIN · CNE100000FN7 LEI · 529900N54X78YH9JYK92 HKEX Wholesale and retail trade
Open in API
Filings indexed 1,610 across all filing types
Latest filing 2024-05-24 AGM Information
Country CN China
Listing HKEX 1099

About Sinopharm Group Co. Ltd.

http://www.sinopharmholding.com

Sinopharm Group Co. Ltd. is a major state-owned enterprise recognized as the largest pharmaceutical logistics provider in Asia and a leading distributor and retailer of healthcare products. The company's core business revolves around providing comprehensive medical supply chain services, encompassing the wholesale and retail distribution of pharmaceuticals, medical devices, and general healthcare products. Sinopharm serves a broad customer base, including hospitals, primary health service institutions, and retail pharmacies. Furthermore, the Group maintains an integrated ecosystem that extends beyond distribution into the manufacturing of pharmaceuticals and chemical reagents, medical services, and industry-finance integration, positioning it as a full-spectrum service provider in the healthcare sector.

Recent filings

Filing Released Lang Actions
FORM OF PROXY FOR ANNUAL GENERAL MEETING
AGM Information Classification · 100% confidence The document is a Form of Proxy for the Annual General Meeting (AGM) of Sinopharm Group Co. Ltd. It includes instructions for shareholders to appoint proxies to vote on various resolutions at the AGM, including approval of the board report, supervisory committee report, audited financial statements, dividend distribution, director remuneration, auditor appointment, and other corporate matters. The document is procedural and related to the conduct of the AGM rather than the content of the AGM itself or the financial reports. It does not contain financial statements or detailed financial data but is a proxy voting form for the AGM. Therefore, it fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the AGM, including proxy forms.
2024-05-24 English
NOTICE OF THE DOMESTIC SHAREHOLDERS' CLASS MEETING
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice of a Domestic Shareholders' Class Meeting for Sinopharm Group Co. Ltd. It details the agenda for the meeting, specifically a special resolution to grant the Board a mandate to repurchase H Shares. The document includes meeting logistics, proxy instructions, and shareholder eligibility details. It does not contain financial statements, audit information, or detailed financial results. It is not a report but a formal announcement of a shareholders' meeting and the matters to be voted on. This fits the category of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2024-05-24 English
NOTICE OF THE H SHAREHOLDERS' CLASS MEETING
Capital/Financing Update Classification · 95% confidence The document is a notice for a shareholders' class meeting specifically for H shareholders of Sinopharm Group Co. Ltd. It details the agenda to consider and approve a general mandate for the Board to repurchase H Shares. The document includes procedural information about the meeting, proxy appointments, and voting rights. It does not contain financial statements, audit information, or detailed financial results. It is an announcement of a meeting and the matters to be discussed, specifically related to share repurchase authorization. This fits the category of a Capital/Financing Update (CAP) because it concerns a mandate for share repurchase, which is a capital structure activity. The document length is 7695 characters, which is substantive but the content is clearly a meeting notice focused on capital management rather than a full report or results announcement.
2024-05-24 English
NOTICE OF ANNUAL GENERAL MEETING
AGM Information Classification · 100% confidence The document is a notice of the Annual General Meeting (AGM) for Sinopharm Group Co. Ltd. It includes details about the date, location, and agenda of the AGM, such as approval of the board report, supervisory committee report, audited financial statements, profit distribution, director remuneration, appointment of auditors, share issuance mandates, share repurchase mandates, and authorization for debt financing instruments. The document is a formal notice inviting shareholders to attend and vote at the AGM, not the actual reports or financial statements themselves. It is typical for such notices to precede the meeting where these items are discussed and approved. Therefore, this document fits the category of AGM Information (AGM-R).
2024-05-24 English
(1) PROPOSED DELEGATION OF POWER OF PROVISION OF GUARANTEES FOR SUBSIDIARIES TO THE BOARD (2) GENERAL MANDATE TO ISSUE NEW SHARES (3) GENERAL MANDATE TO REPURCHASE H SHARES (4) PROPOSED CENTRALIZED RE
AGM Information Classification · 100% confidence The document is a circular from Sinopharm Group Co. Ltd. dated 24 May 2024, containing detailed information about several proposals to be considered at the upcoming Annual General Meeting (AGM) scheduled for 13 June 2024. It includes notices of the AGM and class meetings, explanations of proposed resolutions such as delegation of power for guarantees, general mandates to issue new shares and repurchase shares, and centralized registration for debt financing instruments. The document is comprehensive, over 15,000 characters, and includes a letter from the Board, detailed proposals, and meeting notices. It is not merely an announcement of a report or a proxy solicitation but a full circular providing substantive information for shareholders to make informed decisions at the AGM. This fits the definition of AGM Information (AGM-R), which includes presentations and materials shared during the AGM. The presence of detailed meeting notices and proposals confirms this classification. Therefore, the document is best classified as AGM Information (AGM-R).
2024-05-24 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 95% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2024-05-23 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.